Hanover - Delayed Quote EUR

Novavax Inc (NVV1.HA)

7.12

+1.12

+(18.72%)

At close: 7:41:15 PM GMT+2

Novavax, Shake Shack, solar stocks: Trending Tickers

Market Domination hosts Josh Lipton and Julie Hyman go over some of the day's top trending tickers. Novavax (NVAX) stock is soaring after the company's COVID-19 vaccine was approved by the US Food and Drug Administration (FDA). Shake Shack (SHAK) was downgraded by TD Cowen to Hold from Buy, citing limited multiple expansion. Solar stocks, including First Solar (FSLR), Sunrun (RUN), and Enphase (ENPH), are sinking after Republican lawmakers confirmed that clean-energy tax credits will be ending earlier than planned. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 4 hours ago

SHAK

NVAX

RUN
Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers

Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) on the exchange. The US Food and Drug Administration (FDA) approves Novavax's (NVAX) COVID-19 vaccine, sending the pharmaceutical stock surging. Tesla (TSLA) is adding former Chipotle Mexican Grill (CMG) CFO Jack Hartung to its board of directors, effective June 1, when Hartung will be stepping down as the restaurant chain's president and chief strategy officer. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 9 hours ago

COIN

DFS

NVAX
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

On May 19, JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This comes after the Food and Drug Administration (FDA) approved the company’s COVID-19 vaccine, however with limitations. The analyst noted that they view the approval as a solid near-term win for Novavax, Inc. (NASDAQ:NVAX), […]

Insider Monkey 3 hours ago

NVAX
Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine

Novavax Breaks Out as FDA OKs Shot for High-Risk Groups

GuruFocus.com 4 hours ago

NVAX

SNY
Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

A downgrade of the U.S. debt rating by Moody's sent U.S. equities lower and Treasury yields higher at midday.

Investopedia 8 hours ago

TSLA

XIACY

NVAX
Novavax Secures FDA Approval for COVID-19 Vaccine

Novavax (NVAX) on Monday said it received approval from the US Food and Drug Administration for its

PREMIUM
MT Newswires 9 hours ago

NVAX

SNY
Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with rival vaccine makers.

Barrons.com 9 hours ago

NVAX
NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

The FDA grants full approval to Novavax's protein-based COVID-19 vaccine after nearly a two-month delay, albeit with some new conditions.

Zacks 10 hours ago

NVAX

SNY
Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

Investopedia 10 hours ago

NVAX

SNY
Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

(Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot. The U.S. Food and Drug Administration approved the vaccine, Nuvaxovid, but limited its use to individuals aged 65 and older and people over 12 years who have at least one underlying condition that puts them at high risk due to the illness. The conditions on the label are medically unusual but consistent with the chatter to date, said BTIG analyst Thomas Shrader.

Reuters 12 hours ago

NVAX
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™ for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults 65 years and older and individuals 12 through 64 years who have at least one underlying condition that puts them at high risk for severe outcomes from COVID-19 (e.g. asthma, cancer, diab

PR Newswire 12 hours ago

NVAX
Trending tickers: Nvidia, Alibaba, Novavax, Ryanair and Diageo

The latest investor updates on stocks that are trending on Monday.

Yahoo Finance UK 13 hours ago

GBPUSD=X

USD=X

GBP=X
FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions

The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable limitations. Previously available under emergency use authorization for individuals aged 12 and up, the shot is now fully approved only for adults 65 and older, or for those between the ages of 12 and 64 who have […]

Insider Monkey 23 hours ago

NVAX
Novavax (NasdaqGS:NVAX) Reports Q1 2025 Financial Turnaround

Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration agreement with Takeda offers increased flexibility in vaccine development, while the new board appointment of Charles Newton enhances the company's strategic leadership in healthcare. Over the last week, Novavax's shares rose by 13%, slightly exceeding the broader market's 5% increase, indicating...

Simply Wall St. 2 days ago

NVAX
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 6 days ago

NVAX
Novavax First Quarter 2025 Earnings: Beats Expectations

Novavax ( NASDAQ:NVAX ) First Quarter 2025 Results Key Financial Results Revenue: US$666.7m (up by US$572.8m from 1Q...

Simply Wall St. 9 days ago

NVAX
Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 10 days ago

NVAX
NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

Novavax posts encouraging first-quarter results on the back of an additional $603 million in revenues recognized from the termination of two advanced purchase agreements.

Zacks 10 days ago

NVAX

SNY

ADPT
Analysts Just Shipped An Incredible Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Estimates

Novavax, Inc. ( NASDAQ:NVAX ) shareholders will have a reason to smile today, with the analysts making substantial...

Simply Wall St. 10 days ago

NVAX
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ...

Novavax Inc (NVAX) reports a dramatic revenue increase and strategic collaborations, while navigating regulatory hurdles and restructuring efforts.

GuruFocus.com 10 days ago

NVAX

Performance Overview

Return	NVV1.HA	S&P 500 (^GSPC)
YTD	-9.35%	+1.39%
1-Year	-45.69%	+12.45%
3-Year	-85.56%	+52.88%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Novavax Inc (NVV1.HA)

Novavax, Shake Shack, solar stocks: Trending Tickers

Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

Novavax Secures FDA Approval for COVID-19 Vaccine

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

Trending tickers: Nvidia, Alibaba, Novavax, Ryanair and Diageo

FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions

Novavax (NasdaqGS:NVAX) Reports Q1 2025 Financial Turnaround

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax First Quarter 2025 Earnings: Beats Expectations

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

Analysts Just Shipped An Incredible Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Estimates

Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ...

Performance Overview